Our research team has recently discovered ATRIP as a novel breast cancer susceptibility gene candidate by performing whole-exome sequencing (WES) on a cohort of highly familial breast cancer patients with unknown genetic predisposition and a control group of unaffected women from the founder population of Poland. The gene discussed is ATRIP; the disease is breast cancer.